Replies to post #170596 on Biotech Values

[ilpapa]

Further, we would argue that the longer Teva stock continues to underperform, the more likely it is an offer would materialize


Underperform? He must be looking at a chart from three weeks ago.

[DewDiligence]

Teva would be a problematic company for anyone to acquire because of its strong national identity. Possible but not likely, IMO.